COMP <GO>
ITOC vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
iTonic Holdings Ltd (Class A) (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: ITOC 2
— MRK 9
■ METRIC PARITY
LAST: $2.60 (-8.78%) • MKT CAP: $20.9M
options-implied-move
—
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ITOC VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ITOC | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.60% | 74.80% | -12.20 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 20.70% | -55.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -15.52% | 3.42% | -18.94 | MRK | /fcf-yield <GO> |
| Operating Margin | -60.00% | 34.30% | -94.30 | MRK | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 28.10% | -88.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 16.70% | 1.30% | +15.40 | ITOC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.04% | 2.26% | -2.22 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 10.69 | 5.19 | +5.50 | ITOC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.2 | 51.7 | -13.50 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.9M | $361.02B | -$361.00B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ITOC REV | MRK REV | ITOC GROSS % | MRK GROSS % | ITOC FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $523.0K | $65.01B | 62.6% | 74.8% | -$3.2M | $12.36B |
| FY 2024 | $448.2K | $64.17B | 85.0% | 76.3% | -$775.9K | $18.10B |
| FY 2023 | $628.6K | $60.12B | — | — | -$63.6K | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ITOC // BETA —
MRK // BETA 0.92